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Abstract
Apert syndrome is almost always caused by a spontaneous mutation of paternal origin in one of two nucleotides in the
fibroblast growth factor receptor 2 gene (FGFR2). The incidence of this disease increases with the age of the father (paternal
age effect), and this increase is greater than what would be expected based on the greater number of germ-line divisions in
older men. We use a highly sensitive PCR assay to measure the frequencies of the two causal mutations in the sperm of over
300 normal donors with a wide range of ages. The mutation frequencies increase with the age of the sperm donors, and this
increase is consistent with the increase in the incidence rate. In both the sperm data and the birth data, the increase is non-
monotonic. Further, after normalizing for age, the two Apert syndrome mutation frequencies are correlated within
individual sperm donors. We consider a mathematical model for germ-line mutation which reproduces many of the
attributes of the data. This model, with other evidence, suggests that part of the increase in both the sperm data and the
birth data is due to selection for mutated premeiotic cells. It is likely that a number of other genetic diseases have similar
features.
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Introduction
The paternal age effect (PAE), e.g. [1–5], is the phenomenon
whereby the incidence of sporadic cases of certain genetic diseases
increases with the age of the father. The most common explanation
for this effect is that replication of premeiotic cells throughout a
male’sliferesultsintheaccumulationofmoremutationsinthegerm-
line of older individuals, thereby increasing the sperm mutation
frequency. Given the self-renewing behavior of the dividing cell
population, this explanation would suggest a linear increase in the
incidence of sporadic cases with age, whereas several diseases feature
an exponential increase [2,5]. Recently, molecular tests of the PAE
have been made using sperm from normal men [6–9]. In the case of
Apert syndrome [6,7] the results were not consistent among the
different studies. Here, we possibly bridge this discrepancy. We also
arguethat positiveselectionformutatedpremeioticcellsinthe germ-
line can explain unusual details of the relationship between the
father’s age and both an increase in sperm mutation frequency and
the incidence of sporadic cases.
Apert syndrome (Online Mendelian Inheritance in Man
#101200) is an example of a condition exhibiting a PAE. Affected
individuals display prematurely fused cranial sutures and fused
fingers and toes. Virtually all cases arise from a spontaneous
mutation in one of two nucleotides, c.755C.G or c.758C.G
(herein 755C.G and 758C.G, respectively), in the fibroblast
growth factor receptor 2 gene (FGFR2) [10,11]. In all published
cases that we are aware of, the new mutations were of paternal
origin [12,13]. Since the chance of having an affected child
increases exponentially with the father’s age [2], it is expected that
the sperm mutation frequency at these two sites should also
increase exponentially with the donor’s age. One study [6] found
that though the frequencies of both of these mutations increase
with age, their increase is not as great as expected based on the
birth data [2]. These researchers tested the hypothesis that the age
dependent increase in the sperm mutation frequencies in normal
men is sufficient to explain the increase in birth data of affected
children, and they rejected this hypothesis. However, the
sensitivity of their assay may not have been sufficient to test this
hypothesis. In contrast, others [7] found that by testing one of the
mutations (755C.G), the frequency in sperm increases with age,
and they argued that this increase is sufficient to explain their own
birth data set. However, their sample size of men (especially older
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rather small to statistically test the latter conclusion. Possibly
explaining the disconnect between birth data and sperm data for
paternal age diseases, several groups [6,8,9] have suggested that
perhaps mutated sperm are more likely to fertilize the egg than
non-mutated sperm (also see [14]).
In this study, we measure both the 755C.G and 758C.G
mutation frequencies in the sperm of 314 donors, with ages
ranging from 18 to 78. The number of sperm donors examined is
more than double the number in any of the studies discussed in the
previous paragraph. Moreover, the assays we have developed are
highly sensitive, with false positive rates ,4610
27, at least 25
times lower than the earlier methods. We find that not only does
the sperm mutation data show an increase with age but this
increase is consistent with the birth data of affected children. We
make some unusual observations in terms of a non-monotonic
increase in the sperm mutation frequency with age, and the
correlation between the frequencies of the two different Apert
mutations in the same individuals. In addition, we apply to the
observed sperm data a mathematical model for mutation
accumulation in the testes, which we had previously proposed to
explain the selection-based clustering of these mutations in that
organ [15,16], and consider the role that positive selection may
play in explaining the Apert syndrome PAE [7].
Results
Birth data
The birth data [2] is a compilation of three studies published in
1960 [17], 1975 [18], and 1987 [2]. Table 1 in this paper has been
copied from Table 4 in [2]. The age of the fathers has been binned
into seven approximately five-year age categories: #24, 25–29,
30–34, 35–39, 40–44, 45–49, and $50 years. Figure 1 shows the
observed/expected (O/E) ratio as a function of the father’s age.
The ‘‘observed’’ numerator is the number of affected births to
fathers in that age category, and the ‘‘expected’’ denominator is
proportional to the total number of births in the population (the
vast majority of which do not have the disease) to fathers in that
age category. The hypothesis that the sperm data is consistent with
the birth data means that the number of affected births in each age
category is equal to the product of the total number of births in the
Table 1. Birth data.
source Paternal Age
#24 25–29 30–34 35–39 40–44 45–49 50+
Risch 1987 Expected 7.99 8.22 5.38 2.66 1.13 0.41 0.22
Observed 2 5 3 10 2 1 3
O/E 0.25 0.61 0.56 3.76 1.77 2.44 13.64
Blank 1960 Expected 5.61 11.94 9.50 5.59 2.90 1.04 0.41
Observed 1 4 9 14 5 2 2
O/E 0.19 0.34 0.95 2.50 1.72 1.92 4.88
Cohen 1975 Expected 12.07 14.34 10.62 6.33 3.01 1.11 0.52
Observed 3 10 12 10 3 8 2
O/E 0.25 0.70 1.13 1.58 1.00 7.21 3.85
Total Expected 25.67 34.50 25.50 14.57 7.04 2.56 1.15
Observed 6 19 24 34 10 11 7
O/E 0.26 0.55* 0.94 2.33 1.42 4.30 6.09*
Copied from reference [2] Table 4; the two entries marked with an * have been
corrected from mistakes in the original.
doi:10.1371/journal.pgen.1000558.t001
Author Summary
Epidemiological studies show that the incidence of some
genetic diseases increases with the age of the father. This
‘‘paternal age effect’’ is traditionally explained by the fact
that, as men age, the male germ-line cells continue to
divide, and each division presents an additional chance for
mutation. Apert syndrome is an example of such a disease;
virtually all cases are caused by spontaneous base
substitution mutations of paternal origin at either one of
just two sites. In this paper, we measure the frequencies of
these two mutations in the sperm of unaffected men of
different ages and find a frequency increase with age
similar to what has been found in the data on Apert
syndrome births. We also find (1) the increase in mutation
frequency is not strictly monotonic, featuring a decrease
followed by an increase in middle age, and (2) after
normalizing for age, the two mutation frequencies are
correlated within individual donors. The mutation frequen-
cy increase we observed is greater than expected based
just on the number of male germ-line divisions. Along with
other evidence, our data supports a novel explanation for
the paternal age effect whereby Apert syndrome muta-
tions, though harmful to the child, confer an advantage to
premeiotic cells in the male germ-line that carry such a
mutation. A number of other genetic diseases may exhibit
similar features.
Figure 1. Birth data. The solid line is the observed/expected (O/E)
ratio for Apert syndrome as a function of the father’s age [2],
normalized to be one for the youngest age category. The dashed line
shows the increase expected due to the number of germ-line divisions.
doi:10.1371/journal.pgen.1000558.g001
Apert Syndrome Paternal Age Effect
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frequency for that age category. Thus if this hypothesis is true,
the O/E ratio is an estimate of the sperm mutation frequency.
In order to show the increase with the father’s age, the O/E
ratio has been scaled such that the value at the youngest age
category is one. The dotted line shows the increase expected due
to the number of germ-line divisions (later in this paper, we present
a more detailed model). This line was calculated simply by
counting the average number of germ-line divisions for fathers in
each age category, using the estimate that adult self-renewing A-
pale spermatogonia (SrAp) divide every 16 days [19]. These cells
divide asymmetrically to create a replacement SrAp and a
daughter cell whose descendents produce sperm. Thus, assuming
both this division rate and the mutation rate per cell division
remain constant throughout the male’s life, the mutations due to
replication are expected to increase linearly with age. However,
the O/E ratio [2] appears to increase super-linearly, and the 26-
fold increase from the youngest age category to the oldest category
is greater than the 4-fold increase expected due to the number of
germ-line divisions.
Sperm data
We measured the frequency of mutations 755C.G and
758C.G in the sperm of 314 donors (for an additional 9 donors
the frequency was measured for 755C.G but not for 758C.G).
Figure 2A and 2B show these frequencies as a function of the
donor’s age (Note: the y-axis scale is different for Figure 2A and
2B, Figure 3A–3C, and Figure 4A and 4B). A spreadsheet of all the
frequency estimates and 95% confidence intervals is in Table S1.
The confidence intervals for each donor are relatively narrow.
Quantitatively, for mutation 755C.G, for a donor with mutation
frequency estimate x (in units of mutants per million molecules),
the width of the 95% confidence interval is well approximated by
6.1+0.51x. To choose two illustrative examples, if the mutation
frequency is 25 then the 95% confidence interval is 16 to 34, and if
the mutation frequency is 100 then the 95% confidence interval is
71 to 129. The uncertainty in these measurements is considerably
less than the variation between donors observed in Figure 2.
Similarly, for mutation 758C.G, the width of the 95% confidence
interval is well approximated by 8.7+0.80x. In the analyses below,
we will consider both the average mutation frequency and the
median mutation frequency for each age category. Due to the Law
of Large Numbers, we believe the average is a more informative
summary but the median is also of interest, and the conclusions do
not depend on which summary is used. For both mutations, there
are a few donors with mutation frequencies much higher than the
other donors in their age category, and therefore, in general, the
average mutation frequency for an age category is greater than the
median mutation frequency for the same age category.
Comparing sperm data to birth data
Figure 3A and 3B show the average sperm mutation frequencies
for the birth data age categories. The number of sperm donors for
each age category ranges from 39 to 56. Since either one of the
mutations is sufficient to cause Apert syndrome, Figure 3C shows
the sum of these two mutations’ average frequencies.
In order to test the hypothesis that the sperm data is consistent
with the birth data, we performed a likelihood ratio test, which is
described in Materials and Methods and is similar to the approach
described in [8]. If this hypothesis is true then the number of
affected births in each age category is equal to the product of the
total number of births in the population for each age category and
the sum of the 755C.G and 758C.G average sperm mutation
frequencies for that age category. Since there is uncertainty in the
true average sperm mutation frequencies, the statistical test
incorporates a bootstrap step. Based on this test, we cannot reject
the hypothesis that the sperm data is consistent with the birth data
(p-value 0.094). We reach the same conclusion if we use the
median mutation frequency in each age category instead of the
average mutation frequency (explained in more detail in Materials
and Methods). We would like to emphasize that the distribution of
father’s ages for the total births in the population is different for
the donors of contemporary semen samples compared to the
earlier birth studies, but the likelihood test properly takes this
change into account. However, an implicit assumption of this test,
which may not be true and which we examine in the Discussion
Figure 2. The Apert sperm mutation frequencies. (A) 755C.G and (B) 758C.G, as a function of the donor’s age. Three samples with
exceptionally high frequencies are marked with an X with frequency values printed below.
doi:10.1371/journal.pgen.1000558.g002
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frequency for contemporary sperm donors is similar to what would
have been found for the fathers in the populations used for the
birth studies.
The ratio of the average 755C.G sperm mutation frequency
(across all donors) to the average 758C.G frequency is 1.99 (note
the different scale in Figure 2A and 2B, and Figure 3A and 3B).
This ratio is expected from clinical studies on hundreds of patients
where approximately 2/3 of cases are caused by the 755C.G
mutation and the remaining 1/3 by the 758C.G mutation
[10,11].
However, an examination of Figure 1 and Figure 3 shows that
the general agreement between the birth data and the sperm data
is not complete. For the birth data, the O/E ratio increases 26-fold
from the youngest age category to the oldest. By a bootstrap
procedure described in Materials and Methods, the 95%
confidence interval is 7 to 100-fold. For the sperm data, the
increase in the sum of the two mutations’ average frequencies is
Figure 3. The average Apert sperm mutation frequencies. (A) 755C.G, (B) 758C.G, and (C) their sum. The age categories are the same as for
the birth data.
doi:10.1371/journal.pgen.1000558.g003
Figure 4. Computer simulations of the germ-line mutation model. (A) Mutation frequency as a function of age, and (B) average mutation
frequency as a function of age category. Three simulations with exceptionally high frequencies are marked with an X with frequency values printed
nearby.
doi:10.1371/journal.pgen.1000558.g004
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758C.G. By a separate bootstrap procedure described in
Materials and Methods, the 95% confidence interval for the
average sperm data increase is only 4 to 18-fold. Also for the sperm
data, the increase in the sum of the two mutations’ median
frequencies is greater at 18-fold; the confidence interval for the
medians are arbitrarily large because the median mutation
frequency of the youngest age category is sometimes zero.
Further, one of the more striking visual properties of the figures
is the non-monotonic increase. In Figure 3C, for the sum of the
755C.G and 758C.G mutations in sperm, the average
frequency is lower for the 45–49 age category than for the 40–
44 and 50+ age categories. In order to test for significance, we
performed a bootstrap test described in Materials and Methods,
and found that this dip had an 89% bootstrap value, which is near
the significance threshold (bootstrap values greater than 95% are
deemed significant). For the birth data, in Figure 1, the O/E ratio,
which as described previously is expected to be a proxy for the
sperm mutation frequency, is lower for the 40–44 age category
than for the 35–39 and 45–49 age categories. Surprisingly, this dip
is five years earlier than for the sum of the 755C.G and 758C.G
average mutation frequencies in sperm. The birth data [2] is
actually a collection of three separate birth studies initiated many
years apart, and each one features a dip at the same age category.
The bootstrap value of the birth data dip is 93%. While these
bootstrap values are not significant, they suggest some difference
between the sperm data and the birth data. Further, in Figure 3C,
the 755C.G average mutation frequency in sperm has a dip at
the same age category as the sum of the two average mutation
frequencies in sperm: the bootstrap value is 96%. In Figure 3B, the
758C.G average mutation frequency shows a distinct pattern, the
average frequencies for both the 40–44 and the 45–49 age
categories are slightly lower than for the 35–39 and 50+ age
categories. For the sperm data in this paragraph, we reach the
same conclusions if we replace average mutation frequencies with
median mutation frequencies.
Correlation between mutations
Since we have measured the frequencies of the 755C.G and
758C.G mutations in the same individuals, we can compute the
correlation between these frequencies. The standard correlation
coefficient is statistically significant due to both mutation
frequencies, on average, increasing with the donor’s age.
Therefore we propose a different correlation test. We fix a set of
thresholds for each age category and mutation. For example, our
first set of thresholds is the average mutation frequency for that age
category and mutation. We count the number of donors for which
both mutation frequencies are greater than their respective age-
specific thresholds, and then we calculate whether this number is
greater than would be expected by chance assuming that the two
mutation frequencies are independent. Using the set of averages as
the thresholds, by this test there is a significant correlation between
the age-adjusted mutation frequencies (p-value 0.0007). We
obtained similar p-values when we repeated this test using two-
times-the-averages, the medians, and two-times-the-medians as the
set of thresholds. A potential problem with this test is if the
mutation frequency depends on age within the age categories,
however we tested and did not find a significant dependence (data
not shown).
Modeling the mutation process
We have previously proposed a mathematical model for
mutations in the germ-line (see [15,16] for details). Next we
review this model and consider it in relation to the data in the
present study. We propose a modification to the model that might
explain the non-monotonic increase, and we examine how
selection for mutant premeiotic testis cells affects the PAE.
The incidence of Apert syndrome, ,10
25 to 10
26 [20,21], is
relatively high considering that the disease is caused by one of only
two possible nucleotide substitutions, and the average per
nucleotide per generation mutation rate is 10
27–10
29 [22,23].
One hypothesis is that these two nucleotides have much greater
than average substitution rates (mutation hot spot); another
possibility is that, while damaging to the child, these mutations
provide a selective advantage to premeiotic cells in the germ-line
[6–8,15,16,24,25]. Previously, when we divided the testes of three
deceased individuals, ages 45, 54 and 62, into 192 pieces and
measured the mutation frequency in each piece, we found that the
mutant cells were clustered: some testis pieces had mutation
frequencies 3–4 orders of magnitude greater than the rest of the
testis, and 95% of the mutants were found in just 5% of the testis
pieces [15,16]. Moreover, the average mutation frequencies in
these testes were relatively high, ranging from 6.7610
25 to
7.3610
24.
The mathematical model was originally derived to try to explain
these data [15,16]. The model has two phases. In the first phase
(growth phase), cells divide symmetrically and the number of cells
increases exponentially. The germ-line cells of the growth phase
eventually form the self-renewing A-pale spermatogonia (SrAp). In
the second phase (adult phase), beginning at puberty, the SrAp
divide asymmetrically to create a replacement SrAp and a
daughter cell whose descendents produce sperm. In addition,
mutated SrAp occasionally divide symmetrically. The model has
several parameters: the number of growth phase generations
(estimated to be 30, see [15,16]), the number of adult phase
generations (depends on the individual’s age, adult SrAp divide
approximately every 16 days [19]), the mutation rate per cell
division, and the probability the mutated SrAp divides symmet-
rically (called the selection parameter, if this probability is zero
there is no selection). A mutation in the growth phase may
establish a mutation cluster, similar to a Luria-Delbruck jackpot
[26] (earlier mutations, larger clusters). If the selection parameter
is zero, a mutation in the adult phase will not produce a cluster,
only a single mutated SrAp lineage and the relatively small
number of descendent mutant meiotic and postmeiotic cells,
including sperm. However, if the selection parameter is greater
than zero, the occasional symmetric division will allow the number
of mutated SrAp cells to grow locally, similar to a tumor. One of
the main results of our earlier papers [15,16] is that if the selection
parameter is set to zero, one cannot find a mutation rate per cell
division such that the model reproduces both the observed
relatively high average mutation frequency and the mutant cell
clustering. However, if the selection parameter is greater than
zero, one can find values for this parameter and the mutation rate
per cell division such that both the observed overall frequency and
the clustering are reproduced. (As further support for the selection
hypothesis, when we repeated the testis dissection experiment for
two younger donors, ages 19 and 23, the mutation clusters were
either non-existent or had far fewer mutant cells, suggesting that
the clusters in the older donors were not due to a mutation event
early in development but had grown in the adult [15]. Moreover,
when we assayed a different, presumably neutral nucleotide
substitution at another locus in one of the older donor’s testis, the
mutant cells were distributed randomly without any clusters,
suggesting that the disease mutations are special [16].)
Since the model simulates the spatial distribution of mutants in
the testis, from this distribution we can calculate the mutation
frequency for the entire testis. Based on our earlier work [15,16],
Apert Syndrome Paternal Age Effect
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sperm in the attached epididymis. Therefore, in this study, we
compare the sperm data to a simulated data set, where for each
sperm donor, we use the model to simulate two testes’ frequencies,
and then average these values to get the simulated sperm mutation
frequency. The number of adult phase generations in each
simulation depends on the age of the sperm donor; further details
of the computer simulation program are discussed in Materials
and Methods.
The first realization is that, without additional modification, the
model cannot possibly reproduce the observed non-monotonic
increase in mutation frequency with age. We address this situation
by modifying the model. In the adult testis, we model the SrAp, or
‘‘self-renewing’’ A-pale spermatogonia, but there are also
‘‘reserve’’ A-dark spermatogonia (Ad) [27]. The SrAp cells
regularly divide to make the precursors of sperm while the A-
dark cells are for the most part quiescent [27–29]. However, if the
number of SrAp cells is diminished, the Ad cells are thought to
become active and transform into SrAp cells [28,30]. Since Ad
cells are not regularly dividing, they are thought to be less likely to
have acquired any disease mutations. Therefore when mutated
SrAp cells die they are possibly replaced by fresh, non-mutated Ad
cells. If enough of this death and replacement occurs in middle
age, it can cause a dip in mutation frequency. Figure 4 shows a
simulation of the model incorporating the modifications discussed
in this and the following paragraphs (details in Materials and
Methods). The size of the dip in Figure 4B is similar to that
observed for mutation 755C.G in Figure 3A.
The selection process produces an exponential growth of
mutation clusters. This growth results in a more rapid increase
of mutation frequency with age than the linear increase tied to the
number of germ-line divisions for a neutral process (see Figure 1).
Moreover, it allows for the dramatic increase in mutation
frequency in the very next age category after the category with
the decrease in frequency. As is typical with exponential processes,
the amount of increase depends sensitively on the model
parameters.
Two difficulties with the modified model are that (1) for older
individuals the simulated sperm mutation frequencies are
unrealistically high, and (2) unlike the sperm data for younger
donors the simulated frequencies are all low and similar in value.
In the model, after age 13 (puberty), the SrAp divide every 16
days. It seems reasonable that this cycle might lengthen as an
individual ages, leading to fewer cell generations and slowing the
exponential growth of mutants. However, it is difficult to
estimate this cycle length in humans: to our knowledge only
one experiment was ever done [19], and neither the number of
volunteers for testicular injection of
3H and repeated biopsy, nor
their ages, was given. We have modified the model in a simple
way, stopping all cell generations at age 60. As we have already
said, the uncertainty in the sperm mutation frequency measure-
ments is relatively small, and therefore cannot explain the
problem (2). For the simulations shown in Figure 4, all model
parameters other than age are the same for all donors. We have
attempted to increase the variability in simulated frequencies for
younger donors by letting different donors have different
parameters (randomly selected from a range of parameter
values, simulations not shown) but this change did not reproduce
the variability observed in the sperm data.
Discussion
We measured the frequency of the 755C.G and 758C.G
mutations in the sperm of 314 donors. Either mutation will cause
Apert syndrome. On average, the frequency of both of these
mutations increases with the age of the donor. We compared the
actual distribution of the ages of fathers of affected children to
that expected from the sperm data, namely, the normalized
product of the distribution of the ages of all fathers in the
population (the vast majority of whose children do not have the
disease) and the observed sperm mutation frequency as a
function of the donors’ ages. We then used these distributions
to test the hypothesis that the sperm data is consistent with the
data on sporadic births of affected children in men of different
ages, and we were not able to reject this hypothesis. Our results
provide strong statistical support for the idea that the Apert
syndrome PAE results from an increase in sperm mutation
frequency. These results disagree with one paper [6], presumably
due to the lack of sensitivity in that study’s assay, but agree with
the conclusions of another paper [7], even though these authors
did not have enough data to test this hypothesis statistically.
Despite this agreement, the increase from the youngest age
category to the oldest age category is greater for the birth data
than for the sperm data: 26-fold for the birth data and 9-fold for
the average sperm mutation frequency or 18-fold for the median
sperm mutation frequency. One possible explanation for this
discrepancy is uncertainty in the estimates of the fold-increase
for both the birth data and the sperm data. Although a selective
advantage in fertilization for sperm carrying either Apert
mutation over wild-type sperm is not required to explain this
data, such a possibility could be another contributing factor
[6,14].
It is perhaps most clear from Figure 1, that the PAE for Apert
syndrome is most likely not due only to more germ-line divisions in
older males than younger males. A possible additional contributing
factor is that the mutation rate per cell division may increase as
men age, perhaps due to a decline in the efficiency of DNA repair
mechanisms or an increase in mutagen exposure. While this
mutation rate per cell division increase is possible, it would result
in a uniform elevation of mutation frequencies throughout the
testes. Therefore, it would not explain the clustering of cells
harboring the Apert mutations in the testes of older donors that we
have observed in previous publications [15,16]. Moreover, it
would not explain the apparent growth of these mutation clusters
as adult men age, since when we previously studied the testes from
two younger individuals, ages 19 and 23 years, the mutation
clusters were either non-existent or had far fewer mutant cells than
in the older donors’ testes [15]. We have previously proposed a
model for mutation in the male germ-line [15,16]. This model
includes positive selection, in the form of occasional symmetric
divisions, on the mutant premeiotic testis cells. These occasional
symmetric divisions allow the number of mutant cells to grow
locally in the testis, similar to a tumor. Crow [1] independently
proposed a similar selective mechanism. In this paper and our
previous publications [15,16], we estimate the mutant cells divide
symmetrically approximately 1% of the time; this value is sufficient
to explain both the mutation clusters observed in the older donors’
testes and the growth of these clusters as adult men age. We are
now arguing that this same selection scheme can also help to
explain the increase in the PAE that is greater than would be
expected just from the larger number of germ-line divisions in
older males than younger males.
Both the sperm data and the birth data, as demonstrated by the
O/E ratio, show a non-monotonic increase with age. For the birth
data, researchers had previously declared this observation
‘‘difficult to explain’’ with any model that accumulates mutations
with age during spermatogenesis [2]. These researchers suggested
two possibilities: (1) heterogeneous division rates for the stem cells
Apert Syndrome Paternal Age Effect
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more likely to harbor mutations and to die earlier, and/or (2) an
introduction of fresh, undivided reserve stem cells at middle age.
We have now incorporated the reserve stem cell possibility into
our model for mutation in the germ-line, and simulations from the
modified model reproduce the middle age decrease. In addition to
this decrease, in both the sperm data and the birth data, there is a
dramatic increase in frequency by the very next age category.
While possibilities (1) and (2) cannot explain this dramatic
increase, simulations of our model do reproduce it, due to the
selection on premeiotic testis cells carrying the Apert mutations.
Not all PAE diseases feature a non-monotonic increase [2]. The
type of causal mutation most likely has an effect on this property
(base substitution, deletion, duplication, etc., reviewed in [31]).
Interestingly, even for the Apert syndrome sperm data, the two
causal base substitution mutations display different non-monotonic
patterns. These two mutations are just three base pairs apart
within the same gene, but subtle phenotypic differences (severity of
syndactyly and the presence of cleft palate) [12,32,33] exist
between them. In addition, functional differences between the two
mutants in in vitro assays are known [32,34–36].
The dip for the sum of the two Apert mutation frequencies in
sperm is five years later than for the birth data. An implicit
assumption of the generalized likelihood ratio test is that the
increase in the sperm mutation frequencies for contemporary
donors is similar to what would have been found for the
population of fathers in the earlier birth studies. There is some
evidence [37,38] that contemporary male youths begin puberty at
younger ages (resulting in more mutation events at an earlier ages),
but this evidence is not conclusive [39]. Moreover, [40] report that
there has been a decrease in semen quality over the last fifty years
(also see [41,42] and the contained references for more analysis).
The effects of these or other possible generational changes
(including environmental exposures) are not clear, but it is
conceivable that they could influence the observed difference in
the timing of the non-monotonic increase between the sperm data
and the birth data.
In a previous publication we showed that the two Apert
mutations arise independently within any one testis [15]. It was
therefore unexpected that we observed a significant correlation,
after normalizing for age, between the two mutation frequencies
within individual sperm donors. Perhaps this correlation observa-
tion is due to some property which is heterogeneous across the
population but similar for cells within a single individual.
Variation in properties such as the mutation rate per cell division,
the cell division rate, or the selection coefficient for cells harboring
the mutations could result from genetic or environmental causes. It
would be interesting to collect mutation frequencies at additional
nucleotide sites from these same individuals, to examine whether
some individuals have higher overall mutation frequencies than
others.
Finally, achondroplasia, the most common form of dwarfism
(OMIN # 100800) also shows a PAE. Almost all cases are due to a
spontaneous mutation of paternal origin, at a single nucleotide site
in the fibroblast growth factor receptor 3 gene (FGFR3) [43–46].
This disease however features a monotonic increase in both birth
data [2] and sperm data [8,9]. Also, unlike Apert syndrome, the
age-dependent increase in the sperm mutation frequency for
achondroplasia is not sufficient to explain the birth data ([8], for
another interpretation see [8,47]). However, additional studies are
needed (including complete testis dissection analysis and the
development of more sensitive assay methods) before the
mechanisms behind this disease’s PAE can conclusively be thought
as being the same or different from Apert syndrome.
Materials and Methods
Sperm donors
The majority (80%) of the study semen samples were collected
from partners of women undergoing evaluation for infertility at the
Endocrine/Infertility Clinic of the Los Angeles County/University
of Southern California Keck School of Medicine Medical Center.
The study was approved by the Institutional Review Board of the
University of Southern California. Other samples were recruited
from the greater Baltimore area (Johns Hopkins Hospital (EWJ))
and approved by the JHH IRB. The remaining samples were
recruited from men who are members of a large Venezuelan
kindred, many of whom have Huntington’s disease, and was
approved by the Columbia Presbyterian Medical Center (CPMC)
IRB (NSW).
Molecular assays
The PAP assays [48] to measure the 755C.G and 758C.G
mutation frequencies in sperm were described previously [15,16].
Sperm mutation frequency estimation
Initially, for each donor, 40 reactions were performed using
amounts of DNA (25,000 genomes per reaction) expected to
contain less than one mutant per reaction [15,16]. If 25 or more
reactions were positive, we then diluted the sample and repeated
the experiment until less than 25 out of 40 positive reactions were
obtained. For some donors, multiple dilutions were required. For
some donors, there were multiple replicates. The maximum
likelihood mutation frequency estimates and confidence intervals
were calculated assuming a Poisson distribution.
Birth data
The birth data is the ‘‘Total’’ entries in Table 4 of [2], which
has been reproduced in this paper as Table 1.
Likelihood ratio test
The likelihood ratio test is similar to that described in [8]. The
null hypothesis is that the sperm data is consistent with the birth
data. The birth data we consider is the number of affected births to
fathers in each age category (the ‘‘Total: Observed’’ row in
Table 1). Given that such a birth occurs, we calculate the
probability that the father is in each of the 7 age categories under
the null and alternate distributions (described below). Assuming
the affected births are independent, we then calculate the
likelihood of all the affected births under these two distributions
and take the ratio. The null distribution is proportional to the
product of the total number of births in the population for each
age category (the vast majority of which do not have Apert
syndrome; the ‘‘Total: Expected’’ row in Table 1) and the sum of
the average 755C.G and 758C.G sperm mutation frequencies
for that age category. The alternate distribution is the multinomial
distribution inferred from the number of affected births. In order
to determine the significance of this likelihood ratio, we iterate the
following procedure, which simulates data under the null
hypothesis while taking into account the uncertainty in the true
averages of the sperm mutation frequencies: (1) simulate an
affected births data set by randomly sampling from the null
distribution (the simulated data set has the same number of
affected births as the actual data set), (2) for each age category
obtain a random average sperm mutation frequency by perform-
ing the bootstrap (with replacement) on the sperm mutation
frequencies for that age category, (3) calculate a random null
distribution proportional to the product of the total number of
births in each age category and the random sperm mutation
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for this simulated birth data set where the two distributions are the
random null distribution and the multinomial distribution inferred
from the simulated birth data set. Finally, we compare the
likelihood ratio for the actual data to this set of simulated ratios.
We also repeated this procedure using the median mutation
frequencies for each age category (both when we use all the data
and a random subset).
Since for the birth data we only know the age of the fathers to
the resolution of the listed age categories, and since human
pregnancy is approximately nine months, in order to better
compare the birth data to the sperm data, we have added one year
to the age of each of the sperm donors throughout this study.
Further, we feel confident assuming the distribution of affected
fathers’ ages is uniform in each age category, as is the age of sperm
donors, except for the oldest age category. Therefore, we have
repeated the likelihood ratio test several times where for the oldest
age category we have considered those sperm donors with ages
50–55, 50–60, 50–65, and 50+. This distinction did not affect our
conclusions.
Bootstrap
There are separate bootstrap procedures for the sperm data and
the birth data. For the sperm data, for each iteration, we sample
(with replacement) mutation frequencies within each age category.
For each sample, we then compute the quantity of interest,
namely, the average (or median) mutation frequency fold-increase
from the youngest to the oldest age category, or whether or not the
average (or median) frequency for the 45–49 age category is lower
than for both the 40–44 and 50+ age categories. For this second
quantity, the bootstrap value is the fraction of iterations for which
this dip is present; we deem the result significant if the bootstrap
value is greater than 95%.
For the birth data, for each iteration, we sample (with
replacement) the ages of the fathers of affected children from the
‘‘Total: Observed’’ row in Table 1. We calculate the O/E ratio
using the ‘‘Total: Expected’’ row in Table 1. Similar to above, for
each sample, we then compute the quantities of interest on this
random O/E ratio, except here we are interested in whether there
is a dip such that the ratio for the 40–44 age category is lower than
for the 35–39 and 45–49 age categories.
Modeling the mutation process
The mutation model is a modification of our earlier model
[15,16]. The modified computer code can be found at the website,
http://www-hto.usc.edu/people/petercal. For each individual,
the model is independently simulated two times to represent the
two testes; the mutation frequency in the two testes is calculated
and averaged to get the simulated sperm mutation frequency. The
number of adult phase generations depends on the age of the
donor (a in years) according to the formula, 236(a213),
(approximately one generation every 16 days [19] so 23 per year,
starting at puberty). As discussed in the Results Section, the cell
divisions are stopped at age 60. The major modification to the
model is we allow SrAp cells to die and be replaced by fresh, non-
mutated cells (the number of SrAp cells remains constant in the
modified model). This modification introduces an additional
parameter to the model: in every cell generation between the ages
of 44 and 48, each SrAp (regardless of whether or not it is mutated)
may die and be replaced with probability d. (We first tried modeling
this process a different way, by letting each SrAp cell have a lifetime
drawn from an exponential distribution with mean 47 years, but this
did not produce the sharp dip observed in the sperm data). We
searched the model-parameter space to find values such that, (1) the
sperm mutation frequency for the older age categories is
approximately what was observed for the 755C.Gs p e r mm u t a t i o n
frequency data, (2) the magnitude of the dip was about what was
observed for this data set, and (3) for donors older than age 45, the
simulated spatial distribution of mutants in the testis was such that
95% of the mutants are found in approximately 5% of the testis
pieces (this clustering had been observed experimentally previously
[15,16]).TheparametervaluesinFigure 4that satisfiedthesecriteria
are 5610
211 for the mutation rate per cell division (approximately
two times greater than the value estimated from testis data for the
original, unmodified model without cell death and replacement
[15,16]), 0.014 for the selection parameter (similar to the value
estimated from testis data for the original model [15,16]), and 0.037
for the death probability d (this parameter is new to the modified
model and was not in the original model). These values imply that
mostof the SrAp cells die and are replaced inmiddle age. This death
and replacement does not happen all at once but is spread out
among the cell generations between the ages of 44 and 48; each
generation some mutated cells may be lost but the number of
mutated cells may also increase due to new mutations or symmetric
divisions. Therefore, in general, this process does not eliminate
mutation clusters but just temporarily retards their growth. In our
model whenSrAp die theyare always replaced,this ismostlikely not
true, but sincethenumberof SrAp inolder individualsisnolessthan
a thirdthe number inyounger men [49], we donot believeincluding
this further complication would appreciably affect the model results.
Supporting Information
Table S1 Spreadsheet of 755C.G and 758C.G sperm
mutation frequencies and 95% confidence intervals for all donors
and their ages.
Found at: doi:10.1371/journal.pgen.1000558.s001 (0.08 MB
XLS)
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